Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Total Assets for the year ending September 30, 2023: USD 1.21 B

Embecta Corp Total Assets is USD 1.21 B for the year ending September 30, 2023, a 11.78% change year over year. Total Assets is the total value of all assets owned by a company, representing its resources.
  • Embecta Corp Total Assets for the year ending September 30, 2022 was USD 1.09 B, a 37.87% change year over year.
  • Embecta Corp Total Assets for the year ending September 30, 2021 was USD 788.00 M, a 6.78% change year over year.
  • Embecta Corp Total Assets for the year ending September 30, 2020 was USD 738.00 M.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email